GlassScriptPhysician profile
Madison Smith
NPI 1881393940
$565.81
in general payments reported to CMS, 2019-2025
12 companies · $297 in 2025
The $297 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $134 · 2024: $134 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $565.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $150.42 | 2025 | Zurzuvae |
| Abbvie INC. | $90.88 | 2023-2025 | |
| Astellas Pharma US INC | $69.49 | 2023-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $54.23 | 2023-2024 | |
| Organon LLC | $54.17 | 2023-2024 | Nexplanon |
| Shield Therapeutics INC | $30.10 | 2024 | |
| Evofem Biosciences, INC. | $23.75 | 2025 | Phexxi, Solosec, Phexx |
| Pfizer INC. | $22.32 | 2023 | |
| Mayne Pharma Commercial LLC | $20.03 | 2025 | |
| Cranial Technologies, INC | $19.16 | 2023 | Doc Band |
| Exeltis, USA INC. | $17.72 | 2025 | Slynd |
| Novo Nordisk INC | $13.54 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madison Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.